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SUMMARY
Despite the importance of lower respiratory-tract infection (LRI) in causing hospitalizations in
elderly patients (o65 years of age) and recent advances in vaccine development, a complete
picture of the causative organisms is not available. All hospital discharge diagnoses (ICD-10
code) for LRI in elderly patients in England during 1995–1998 were reviewed. Using known
seasonality in potential causative agents of LRI, the contribution of diﬀerent respiratory
pathogens to hospitalizations coded as ‘unspeciﬁed LRI’ was estimated by multiple linear
regression analysis. Ninety-seven per cent of 551 633 LRI-associated diagnoses had no speciﬁc
organism recorded. From the statistical model the estimated proportions of admissions
attributable to diﬀerent pathogens were applied to calculate estimated hospitalization rates : 93.9
hospitalizations/10 000 population agedo65 years due to S. pneumoniae, 22.9 to inﬂuenza virus,
22.3 to H. inﬂuenzae, 17.0 to whooping cough, and 12.8 to respiratory syncytial virus. There is
enormous potential to improve health using existing vaccines and those under development.
INTRODUCTION
Despite the importance of lower respiratory-tract in-
fection (LRI) in causing hospital admissions in the
elderly, a complete picture of the causative organisms
has not been available for a number of reasons. For
some organisms, most notably respiratory syncytial
virus (RSV) and Bordetella pertussis a role in causing
LRI in the elderly has only been recognized relatively
recently [1–4]. In general, clinicians do not investigate
for virological causes of LRI such as inﬂuenza virus
or RSV in adults because a speciﬁc diagnosis does
not necessarily change management of patients in the
absence of any treatment. If clinicians do investigate,
they still may not obtain a speciﬁc diagnosis because
signiﬁcant change occurs with age in some laboratory
values [5] or they may face the problem that blood
cultures are insensitive methods to diagnose, for
example Streptococcus pneumoniae, a major bacterial
cause of LRI. Consequently, laboratory-based sur-
veillance grossly under-ascertains morbidity from the
causative organisms of LRI in the elderly.
Several factors are increasing the priority of having
good estimates of the contribution of each organism
to the burden of LRI and of how much can be pre-
vented. The place of new vaccines needs to be deﬁned,
including the licensed conjugate pneumococcal
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vaccine and those in development for infections
such as RSV [6]. Changes in existing vaccination
programmes such as those implemented in the United
Kingdom for inﬂuenza in 2000 [7] and consideration
of new pneumococcal vaccines would beneﬁt from
more comprehensive evaluation.
Increasing antibiotic resistance has led to policies to
minimize unnecessary antibiotic use and to promote
use of narrow-spectrum antibiotics targeted at speciﬁc
agents. These require accurate microbiological di-
agnosis. In addition, anti-viral agents have been
developed [8], and new agents are in development. A
better understanding of the role of diﬀerent organisms
in causing LRI admissions may help direct rational
use of anti-bacterial and anti-viral agents in hospitals.
In the past community-based studies have aimed to
produce a comprehensive picture. These have been
limited for a number of reasons. Some studies have
been biased towards either bacterial or viral causes of
LRI and most have identiﬁed the aetiological agent in
the minority of recruited patients [9, 10]. Although
advanced diagnostic methods such as polymerase
chain reaction assays have improved diagnostic yield,
such studies still have to be large and run for several
years to include organisms with epidemic cycles,
making them costly and diﬃcult to carry out.
Modelling has the potential to complete the patchy
picture given by surveillance and sporadic descriptive
studies. In this study we use a simple statistical model
to estimate the proportion of unspeciﬁed pneumonia,
bronchitis and chronic obstructive pulmonary disease
(COPD) related hospitalizations in the elderly due to
S. pneumoniae, RSV, inﬂuenza, B. pertussis and other
important infectious causes of respiratory disease.
METHODS
Hospitalization data
The number of all patients hospitalized with a diag-
nosis of LRI in England was obtained from the
hospital episodes statistic (HES) database from April
1995 to March 1998. This database contains the
personal, medical and administrative details of all
patients admitted to NHS hospitals in England. This
represents a population ofy49 million people. Using
personal identiﬁers such as date of birth and postal
code, duplicates were identiﬁed and excluded.
Elderly patients (o65 years of age) were selected if
the diagnosis in any of the seven diagnostic ﬁelds in
their HES record matched the following International
Classiﬁcation of Diseases, 10th Revision (ICD-10)
codes for LRI: pneumonia (J12-18), acute bronchitis
(J20), acute bronchiolitis (J21), unspeciﬁed acute lower
respiratory infection (J22), bronchitis, not speciﬁed as
acute or chronic (J40), inﬂuenza (J10, J11), other
chronic obstructive pulmonary disease with acute
lower respiratory tract infection/acute exacerbation,
unspeciﬁed (J44), whooping cough (A37), Legion-
naires ’ disease (A48), Chlamydia psittaci infection
(A70).
Statistical model
Multiple linear regression analysis was applied to es-
timate the proportion of unspeciﬁed LRI hospital-
izations to diﬀerent respiratory pathogens in the
elderly. These statistical models were constructed as
described previously [11, 12]. The technique uses the
observed temporal variation in potential causative
pathogens for pneumonia, bronchitis and COPD to
estimate the level of under-diagnosis for each of these
causes.
The dependent variables in the regression analysis
were the weekly number of admissions in patients
agedo65 years due to unspeciﬁed pneumonia (ICD-
10: J12.8/9; J15.8/9; J18), unspeciﬁed bronchitis/
bronchiolitis (ICD-10: J20.9, J21.9) and unspeciﬁed
COPD (ICD-10: J44.0/1), respectively. Admissions
with a LRI due to whooping cough, Chlamydia,
Escherichia coli, Haemophilus inﬂuenzae, inﬂuenza
virus, Klebsiella pneumoniae, Legionella spp., Myco-
plasma pneumoniae, parainﬂuenza virus, rhinovirus,
RSV, S. pneumoniae, streptococci other than
S. pneumoniae, and Staphylococcus were included as
independent variables. Also, a variable named ‘other’
was deﬁned to account for organisms not suﬃciently
numerous to include separately (coxsackievirus,
echovirus, Pseudomonas) and for non-infectious
causes of LRI (allergic asthma, non-allergic asthma,
mixed asthma). The variable ‘dual infections ’ in-
cluded admissions due to more than one of the above-
mentioned causative organisms.
After conﬁrming that the underlying seasonal
pattern was the same in all age groups, data from all
age groups were used for the independent variables
to make the seasonal trends more distinct. Backwards
stepwise regression was performed to remove vari-
ables that did not contribute to the model using SPSS
for Windows, version 10.0 (SPSS Inc., Chicago, IL,
USA). In a step-by-step procedure single variables
that reduced R2 by the smallest increment were
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removed from the equation if the resulting decrease
was not statistically signiﬁcant by the F test (signiﬁ-
cance level of F value <0.05). The procedure was
continued until the removal of a variable caused a
signiﬁcant reduction in the overall model ﬁt.
Validity of the ﬁnal models (modelpneumonia,
modelbronchitis and modelCOPD) was conﬁrmed by
analysis of residual plots. The analysis was performed
using SPSS for Windows, version 10.0 (SPSS Inc.).
Calculating hospitalization rates
The observed hospitalization rates for S. pneumoniae,
inﬂuenza virus, H. inﬂuenzae, whooping cough,
RSV, streptococci other than S. pneumoniae, and
K. pneumoniae were calculated using denominators
derived from the annual resident population estimates
based on the projections of the 1991 UK census
(Oﬃce for National Statistics).
From the statistical model the estimated
proportions of admissions attributable to the
above-mentioned respiratory pathogens were applied
to calculate estimated hospitalization rates for each
pathogen.
RESULTS
Hospitalizations in the elderly, HES data
HES records associated with LRI were found for
551 633 patients aged o65 years during the 3-year
study period. Table 1 shows the number and diagnosis
of LRI-associated hospitalizations. Ninety-seven per
cent of these admissions did not have a speciﬁc or-
ganism recorded in any of the diagnostic ﬁelds, and
are deﬁned here as ‘LRI due to unspeciﬁed organism’.
Of these unspeciﬁed diagnoses, 92% were diagnosed
as pneumonia, 6% as COPD, and <1% were diag-
nosed as bronchitis/bronchiolitis, and ‘ inﬂuenza
(virus not identiﬁed)’ respectively. Of the remaining
16 916 patients with a speciﬁc diagnosis for LRI,
33% were diagnosed with S. pneumoniae, 8% with
H. inﬂuenzae, 7% with streptococci other than
S. pneumoniae, 6% with Staphylococci, 5% with
M. pneumoniae, and 2% with K. pneumoniae. Less
than 1% of the patients were diagnosed with E. coli,
RSV, inﬂuenza virus, Legionella spp., parainﬂuenza
virus, rhinovirus whooping cough, Chlamydia, or
with more than one speciﬁc LRI (‘dual infection’)
respectively. Thirty-ﬁve per cent of the patients
belonged to the category ‘other’ (allergic asthma,
non-allergic asthma, mixed asthma, coxsackievirus,
echovirus, Pseudomonas).
Results of statistical models for unspeciﬁed
pneumonia, bronchitis, and COPD
Unspeciﬁed LRI-associated hospitalizations in the
elderly due to speciﬁc respiratory pathogens were
estimated using three models : modelpneumonia,
modelbronchitis and modelCOPD. Table 2 demonstrates
Table 1. Number and diagnosis of lower respiratory-
tract infection (LRI)-associated hospitalizations in the
elderly (o65 years), England, April 1995 to March
1998
Diagnosis
No. of
admissions
% of LRI
patients
Unspeciﬁed LRI, of those 534 717 96.93
Pneumonia 494 309
Chronic obstructive
pulmonary disease
32 843
Bronchitis/bronchiolitis 4549
Inﬂuenza (virus not identiﬁed) 2837
Mixed (>1 unspeciﬁed LRI) 179
Other (asthma, coxsackievirus,
echovirus, Pseudomonas)
5954 1.08
S. pneumoniae 5628 1.02
H. inﬂuenzae 1285 0.23
Streptococci other than
S. pneumoniae
1220 0.22
Staphylococcus 1009 0.18
M. pneumoniae 823 0.15
K. pneumoniae 353 0.06
E. coli 162 0.03
Respiratory syncytial virus 157 0.03
Inﬂuenza 151 0.03
Legionella spp. 68 0.01
Dual infections 64 0.01
Whooping cough 16 0.00
Chlamydia 16 0.00
Parainﬂuenza 9 0.00
Rhinovirus 1 0.00
Total 551 633
Table 2. Covariates in modelpneumonia
Coeﬃcient P value 95% CI
Whooping cough 10.06 <0.001 6.15–13.98
H. inﬂuenzae 19.87 <0.001 7.77–31.97
Inﬂuenza 75.67 <0.001 59.60–91.73
RSV 1.12 <0.001 0.81–1.44
S. pneumoniae 19.76 <0.001 16.00–23.52
Other 16.82 <0.001 11.29–22.34
RSV, respiratory syncytial virus ; CI, conﬁdence interval.
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the modelpneumonia for unspeciﬁed pneumonia. The
variables admission due to whooping cough,
H. inﬂuenzae, inﬂuenza virus, RSV, S. pneumoniae,
and ‘other ’ remained in the ﬁnal model. The adjusted
R2 of modelpneumonia indicates that 90% of the
variation in the weekly number of unspeciﬁed cases
was explained by the model. Figure 1 demonstrates
both the ﬁt of the model and what proportion of
hospitalizations are caused by the diﬀerent organisms
at diﬀerent times. Using this model, it was estimated
that 42.1% of unspeciﬁed pneumonia could be at-
tributed to S. pneumoniae, 9.8% to inﬂuenza virus,
9.1% to H. inﬂuenzae, 7.4% to whooping cough,
5.1% to RSV and 26.6% to other causes (Table 3).
An adequate ﬁt was also achieved for modelbronchitis
and modelCOPD as indicated by an R
2 of 0.80 and 0.78
respectively (Tables 4 and 5, and Figs 2 and 3). The
ﬁnal modelbronchitis contained the variables inﬂuenza
virus, RSV, S. pneumoniae, and ‘other’, and for
modelCOPD, whooping cough,H. inﬂuenzae, inﬂuenza
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Fig. 1. Comparison of observed bi-weekly number of unspeciﬁed pneumonia hospitalizations in the elderly (o65 years) with
estimated number due to S. pneumoniae, inﬂuenza. B. pertussis, respiratory syncytial virus (RSV), and other causes based on
the ﬁnal modelpneumonia shown in Table 2.
Table 3. Estimates of the proportion of unspeciﬁed pneumonia,
bronchitis and chronic pulmonary disease hospitalizations in the elderly
(o65 years) due to speciﬁc respiratory pathogens
Pathogen modelpneumonia modelbronchitis modelCOPD
S. pneumoniae 42.1% 51.4% 25.1%
Other 26.6% 22.8% —
Inﬂuenza 9.8% 13.6% 10.5%
H. inﬂuenzae 9.1% — 20.3%
Whooping cough 7.4% — 18.4%
Respiratory syncytial virus 5.1% 12.2% 9.7%
Streptococci other than
S. pneumoniae
— — 10.3%
K. pneumoniae — — 5.8%
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virus, K. pneumoniae, RSV, S. pneumoniae, and
streptococci other than S. pneumoniae remained in the
ﬁnal model. Table 5 shows the estimates of the pro-
portion of unspeciﬁed bronchitis and unspeciﬁed
COPD due to the speciﬁc respiratory pathogens.
We excluded the intercept in all three models as the
variable ‘other ’ accounted for organisms not included
as independent variables and for non-infectious cau-
ses. There was little change in the remaining estimated
proportions and the model ﬁt was almost the same.
Hospitalization rates
Applying the results of modelpneumonia, modelbronchitis
and modelCOPD, the number of unspeciﬁed
pneumonia, unspeciﬁed bronchitis and unspeciﬁed
COPD hospitalizations in the elderly were calculated
for each pathogen for the 3-year study period.
Derived from these estimates the mean annual
incidence of hospital admissions attributable to S.
pneumoniae, inﬂuenza virus, H. inﬂuenzae, whooping
cough, RSV, streptococci other than S. pneumoniae,
and K. pneumoniae were calculated. Table 6 shows the
observed and estimated LRI-associated hospitaliz-
ation rates.
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Fig. 2. Comparison of observed bi-weekly number of unspeciﬁed bronchitis hospitalizations in the elderly (o65 years) with
estimated number due to S. pneumoniae, inﬂuenza, respiratory syncytial virus (RSV), and other causes based on the ﬁnal
modelbronchitis shown in Table 4.
Table 4. Covariates in modelbronchitis
Coeﬃcient P value 95% CI
Inﬂuenza 0.970 <0.001 0.65–1.29
RSV 0.025 <0.001 0.02–0.03
S. pneumoniae 0.224 <0.001 0.15–0.29
Other 0.134 0.0051 0.04–0.23
RSV, respiratory syncytial virus ; CI, conﬁdence interval.
Table 5. Covariates in modelCOPD
Coeﬃcient P value 95% CI
Whooping cough 1.67 <0.001 1.243–2.090
H. inﬂuenzae 2.95 <0.001 1.677–4.224
Inﬂuenza 5.36 <0.001 3.604–7.112
K. pneumoniae 3.85 0.002 1.381–6.325
Respiratory
syncytial virus
0.14 <0.001 0.109–0.174
Streptococci other
than S. pneumoniae
1.44 0.037 0.087–2.801
S. pneumoniae 0.78 <0.001 0.403–1.165
CI, conﬁdence interval.
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DISCUSSION
The method was applied successfully to generate ro-
bust models which indicate that the impact of the
major respiratory pathogens S. pneumoniae, inﬂuenza
virus, whooping cough, and RSV is far greater than is
routinely recorded. In particular, estimates of the
potential beneﬁts of pneumococcal vaccination based
upon reported numbers of admissions will be gross
under-estimates.
These methods have the advantage over laboratory
data of being potentially more sensitive. This is
because diagnostic tests have limited sensitivity and
clinicians do not always carry out appropriate
investigations such as blood cultures or virology
[13, 14]. Although apparently more sensitive, this
analysis cannot replace laboratory-based surveillance
which remains vitally important. First, availability of
HES is not timely enough for surveillance, and the
data are unwieldy to analyse, so could not be used to
generate warning of epidemics of inﬂuenza or RSV,
for example. Second, this method cannot distinguish
subtypes of an organism such as the pneumococcal
serotypes or diﬀerent inﬂuenza strains if they display
identical seasonality. Finally, a newly discovered
pathogen which has identical seasonality to another
known organism would not be detected by this
method, and could only be identiﬁed through lab-
oratory investigation [15].
The results indicate diﬀerent predominance of dif-
ferent organisms in diﬀerent clinical syndromes
which mirrors clinical observation [16] and lends
Table 6. Comparison of observed and estimated lower
respiratory-tract infection-associated hospitalization
rates due to S. pneumoniae, inﬂuenza virus,
H. inﬂuenzae, whooping cough, RSV, streptococci
other than S. pneumoniae, and K. pneumoniae in the
elderly (o65 years)
Hospitalization/10 000
population agedo65 years
Pathogen Observed Estimated
S. pneumoniae 2.4 93.9
Inﬂuenza virus 0.1 22.9
H. inﬂuenzae 0.6 22.3
Whooping cough 0.01 17.0
Respiratory syncytial
virus
0.1 12.8
Streptococci other
than S. pneumoniae
0.5 2.0
K. pneumoniae 0.2 1.0
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Fig. 3. Comparison of observed bi-weekly number of unspeciﬁed COPD hospitalizations in the elderly (o65 years) with
estimated number due to S. pneumoniae, H. inﬂuenzae, B. pertussis, inﬂuenza, other streptococci, respiratory syncytial virus
(RSV), and K. pneumoniae based on the ﬁnal modelCOPD shown in Table 5.
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validity to the model. Haemophilus, Klebsiella, and
non-pneumococcal streptococci contribute more
greatly to COPD and bronchitis than pneumonia.
These organisms are well recognized as causing ex-
acerbations of chronic respiratory disease. Pertussis
is increasingly recognized as causing atypical respir-
atory illness in adults, and this study indicates that it
may have a signiﬁcant role in causing hospitalization
for pneumonia in elderly patients. In addition, diﬀer-
ent organisms have diﬀerent levels of under-diagnosis
in diﬀerent syndromes as shown by the coeﬃcients
of the covariates in the models. Thus, the models
indicate areas to target for improved methods of
investigation and diagnostic sensitivity. Inﬂuenza
seems to be responsible for around the same percent-
age of admissions for all three syndromes. Future
analyses should be carried out to investigate the
impact of recent changes in inﬂuenza vaccination
policy.
The observed organism-speciﬁc rates of hospital-
ization show the pneumococcus as the most import-
ant cause of LRI overall followed by H. inﬂuenzae.
The rates estimated from the modelling also place the
pneumococcus at the top but move inﬂuenza from
ﬁfth to second in the ranking, and move pertussis up
from bottom to fourth place. Furthermore, they stress
the importance of RSV infection in the elderly, and
the need for an eﬀective RSV vaccine with hospital-
ization rates similar to those found recently by Falsey
et al. [17]. These ﬁndings indicate the value of this
approach which improves the estimates of burden and
also changes the order of priorities for intervention.
For some pathogens, e.g. the pneumococcus, LRI
is only one of the clinical syndromes caused. Others
include septicaemia and meningitis. In addition mild-
er community infections occur which do not result in
hospital admission. The estimates of LRI hospital-
izations, therefore, represent a part of the impact of
these organisms on health.
Although our results give a good indication of
the potential beneﬁts of vaccination they do not indi-
cate the best vaccination policy. Organisms such as
inﬂuenza and pneumococcus have well-established
interactions [18] and vaccination for one may have
additional beneﬁts in preventing a proportion of
another infection which is not estimable from this
analysis. In addition the impact of vaccination for
a subgroup of types, as proposed for the pneu-
mococcus, may have unpredictable results [19].
Mycoplasma did not appear in the ﬁnal models
against expectations. This may be explained by the
fact that the 3 years of the study did not include an
epidemic year and the seasonality of Mycoplasma in
inter-epidemic years may not be strong enough to
appear in the model separately from the background
rate of LRI (‘other’).
This picture of LRI in the elderly shows that there
is enormous potential to improve health using a few
existing vaccines just for this particular clinical syn-
drome. The number of pathogens accounting for most
LRI appears to be small, and for the majority of the
organisms vaccines are already available (inﬂuenza,
pneumococcus, pertussis) or under development
(RSV). The next challenges are to deﬁne the most
cost-eﬀective design of new vaccination programmes,
and decide how they could best be implemented.
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